BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20132767)

  • 1. [Dermal fibroblasts exert a key influence in the development of basal-cell skin cancers: the model of Gorlin syndrome].
    Valin A; Avril MF; Magnaldo T
    Med Sci (Paris); 2010 Jan; 26(1):22-5. PubMed ID: 20132767
    [No Abstract]   [Full Text] [Related]  

  • 2. Basal cell carcinoma and the carcinogenic role of aberrant Hedgehog signaling.
    Saran A
    Future Oncol; 2010 Jun; 6(6):1003-14. PubMed ID: 20528237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The gene of Gorlin's syndrome (basocellular nevomatosis) and the revival of the developmental genes in human carcinogenesis].
    Molès JP
    Bull Cancer; 1998 Mar; 85(3):207-8. PubMed ID: 9752308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTCH1 +/- dermal fibroblasts isolated from healthy skin of Gorlin syndrome patients exhibit features of carcinoma associated fibroblasts.
    Valin A; Barnay-Verdier S; Robert T; Ripoche H; Brellier F; Chevallier-Lagente O; Avril MF; Magnaldo T
    PLoS One; 2009; 4(3):e4818. PubMed ID: 19287498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nevoid basal cell carcinoma (Gorlin) syndrome: unanswered issues.
    Gorlin RJ
    J Lab Clin Med; 1999 Dec; 134(6):551-2. PubMed ID: 10595780
    [No Abstract]   [Full Text] [Related]  

  • 6. Hedgehog fights back: mechanisms of acquired resistance against Smoothened antagonists.
    Metcalfe C; de Sauvage FJ
    Cancer Res; 2011 Aug; 71(15):5057-61. PubMed ID: 21771911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic elimination of Suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway.
    Svärd J; Heby-Henricson K; Persson-Lek M; Rozell B; Lauth M; Bergström A; Ericson J; Toftgård R; Teglund S
    Dev Cell; 2006 Feb; 10(2):187-97. PubMed ID: 16459298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dermoscopy of Gorlin syndrome: pursuit of the pits revisited.
    Jarrett R; Walker L; Bowling J
    Arch Dermatol; 2010 May; 146(5):582. PubMed ID: 20479325
    [No Abstract]   [Full Text] [Related]  

  • 9. Splicing aberration in naevoid basal cell carcinoma syndrome.
    Ishitsuka Y; Furuta J; Miyashita T; Otsuka F
    Acta Derm Venereol; 2012 Nov; 92(6):619-20. PubMed ID: 22434048
    [No Abstract]   [Full Text] [Related]  

  • 10. Palmar pits associated with the nevoid basal cell carcinoma syndrome.
    North JP; McCalmont TH; LeBoit P
    J Cutan Pathol; 2012 Aug; 39(8):735-8. PubMed ID: 22845656
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new drug for basal cell carcinoma].
    Witte F
    Schweiz Monatsschr Zahnmed; 2013; 123(12):1104-6. PubMed ID: 24730087
    [No Abstract]   [Full Text] [Related]  

  • 12. Ultraviolet responses of Gorlin syndrome primary skin cells.
    Brellier F; Valin A; Chevallier-Lagente O; Gorry P; Avril MF; Magnaldo T
    Br J Dermatol; 2008 Aug; 159(2):445-52. PubMed ID: 18510667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset acral basal cell carcinomas in Gorlin syndrome.
    Torrelo A; Vicente A; Navarro L; Planaguma M; Bueno E; González-Sarmiento R; Hernández-Martín A; Noguera-Morel L; Requena L; Colmenero I; Parareda A; González-Enseñat MA; Happle R
    Br J Dermatol; 2014 Nov; 171(5):1227-9. PubMed ID: 24837096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of PTCH1+/- fibroblast lysate and conditioned culture media isolated from the skin of healthy subjects and nevoid basal cell carcinoma syndrome patients.
    Ponti G; Bertazzoni G; Pastorino L; Monari E; Cuoghi A; Bergamini S; Bellei E; Benassi L; Azzoni P; Petrachi T; Magnoni C; Pellacani G; Loschi P; Pollio A; Witkowski AM; Tomasi A
    Biomed Res Int; 2013; 2013():794028. PubMed ID: 24369017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nevoid basal cell carcinoma (Gorlin) syndrome.
    Gorlin RJ
    Genet Med; 2004; 6(6):530-9. PubMed ID: 15545751
    [No Abstract]   [Full Text] [Related]  

  • 16. Patched, hedgehog, and skin cancer.
    Quinn AG; Epstein E
    Methods Mol Biol; 2003; 222():85-95. PubMed ID: 12710681
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel mutation in the PTCH1 gene in a patient with Gorlin syndrome with prominent clinical features.
    Valdivielso-Ramos M; Solera J; Mauleon C; Hernanz JM; Amiñoso C; Galiano S; De la Cueva P
    Clin Exp Dermatol; 2014 Apr; 39(3):406-7. PubMed ID: 24635088
    [No Abstract]   [Full Text] [Related]  

  • 18. Patched mutations and hairy skin patches: a new sign in Gorlin syndrome.
    Wilson LC; Ajayi-Obe E; Bernhard B; Maas SM
    Am J Med Genet A; 2006 Dec; 140(23):2625-30. PubMed ID: 16906569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous mutations in the tumor suppressor gene PATCHED provoke basal cell carcinoma-like features in human organotypic skin cultures.
    Brellier F; Bergoglio V; Valin A; Barnay S; Chevallier-Lagente O; Vielh P; Spatz A; Gorry P; Avril MF; Magnaldo T
    Oncogene; 2008 Nov; 27(51):6601-6. PubMed ID: 18679421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal cell naevus syndrome: an update on genetics and treatment.
    John AM; Schwartz RA
    Br J Dermatol; 2016 Jan; 174(1):68-76. PubMed ID: 26409035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.